Contribution of the disease and its therapy on the SLICC/ACR-DI in early systemic lupus erythematosus;Contribuição da doença e sua terapêutica no índice de dano SLICC/ACR na fase precoce do lúpus eritematoso sistêmico

Revista Brasileira de Reumatologia

Volumn 44, Issue 2, 2004, Pages 123-128

  Bezerra, Mailze Campos ^a   da Silva Júnior, Francisco Saraiva ^a   Neto, Eduardo Ferreira Borba ^a   Bonfá, Eloisa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Damage; SLICC ACR DI; Systemic lupus erythematosus; Therapy

Indexed keywords

EID: 33846688368     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0482-50042004000200004     Document Type: Article

References (31)

1. Abu-Shakra, Urowitz MB, Gladman DD, Gough J: Mortality studies in systemic lupus erytematosus. Results from a single centre. II. Predictor variables for mortality. J Rheumatol 22: 1265-70, 1995.
2. Gladman DD, Ginzler E, Goldsmith C, et al: The development and initial validation of the systemic lupus international collaborating clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39: 363-9, 1996.
3. Gladmann DD, Urowitz MB, Goldsmith CH, et al: The reliability of the systemic lupus international collaborating clinics/American College of Rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum 40: 809-13, 1997.
4. Gladman DD, Urowitz MB. The SLICC/ACR damage index: progress report and experience in the field. Lupus 8: 632-7, 1999.
5. Zonna-Nacach A, Camargo-Coronel A, Yanez P, et al: Measurement of damage in 210 mexican patients with systemic lupus erythematosus: relationship with disease duration. Lupus 7: 119-23, 1998.
6. Nossent JC: SLICC/ACR damage index in afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy and prognosis. J Rheumatol 25: 654-9, 1998.
7. Stoll T, Stucki G, Malik J, et al: Association of the systemic lupus international collaborating clinics/American College of Rheumatology damage index with measures of disease activity and health status in patients with systemic lupus erythematosus. J Rheumatol 24: 309-13, 1997.
8. Tan EM, Chen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-7, 1982.
9. Gharavi AE, Harris EM, Asherson RA, Hughes GRV: Anticardiolipin antibodies isotype distribution and phospholipid specificity. Ann Rheum Dis 46: 1-6, 1987.
10. Kovacs JAJ, Urowitz MB, Gladman DD: Dilemmas in neuropsychiatric lupus. Rheum Dis Clin North Am 19: 795-813, 1993.
11. Stoll T, Seifert B, Isenberg DA: SLICC/ACR damage index is valid and renal e pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 35: 248-54, 1996.
12. Gladman DD, Goldsmith CH, Urowitz MB, et al: The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ ACR) Damage Index for Systemic Lupus Erytematosus International Comparison. J Rheumatol 27: 373-6, 2000.
13. Borba EF, Bonfá E: A first step toward solving the neuropsychiatric lupus puzzle. J Clin Rheumatol 5: 312-3, 1999.
14. Sanni G, Khamashta MA: Low-dose pulse cyclophosphamide in the treatment of neuropsychiatric lupus. Lupus 12: 1-2, 2003.
15. Boumpas DT, Austin HA, Vaughn EM, et al: Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340: 741-5, 1992.
16. Gescuk BD, Davis JC: Novel therapeutic agents for systemic lupus erythematosus. Curr Opin Rheumatol 14:515-21, 2002.
17. Alarcon-Segovia D, Abud-Mendonza C, Diaz-Jouanen E, et al: Deforming arthropathy of the hands in systemic lupus erythematosus. J Rheumatol 15: 65-9, 1988.
18. Bleifeld CJ, Inglis AE: The hand in systemic lupus erythematosus. J Bone Joint Surg 56A: 1207-15, 1974.
19. Dreyfus JN, Schnitzer TJ: Pathogenesis and differential diagnosis of the swan-neck deformity. Semin Arthritis Rheum 13: 200-11, 1983.
20. Esdaile JM, Danoff D, Rosenthal L, et al: Deforming arthritis in systemic lupus erythematosus. Ann Rheum Dis 40: 124-6, 1981.
21. Kahn MF: Jaccoud's syndrome in a rheumatology unit. Clin Rheum Pract Winter: 153-5, 1986.
22. Dubois EL, Cozen L: Avascular (aseptic) bone necrosis associated with lupus erythematosus. J Am Med Assoc 174: 966-84, 1960.
23. Petri M: Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update. Arthritis Care Res 8: 137-45, 1995.
24. Manolagas SC, Weinstein RS: New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 14: 1061-6, 1999.
25. Cunnane G, Lane NE: Steroid-induced osteoporosis in systemic lupus erythematosus. Rheum Dis Clin North Am 26: 311-27, 2000.
26. Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M: Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 24: 654-62, 1997.
27. Egan RM, Munn RK: Catastrophic antiphospholipid antibody syndrome presenting with multiple thromboses and sites of avascular necrosis. J Rheumatol 21: 2376-9, 1994.
28. Korompilias AV, Gilkeson GC, Ortel TL, Seaber AV, Urbaniak JR: Anticardiolipin antibodies and osteonecrosis of the femoral head. Clin Orthop 345: 174-80, 1997.
29. Manzi S, Meilahn EM, Rairie JE, et al: Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus. Am J Epidemiol 145: 408-15, 1997.
30. Boumpas DT, Austin HA 3rd, Vaughan EM, Yarboro CH, Klippel J, Balow JE: Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119: 366-9, 1993.
31. Bootsma H, Derksen RHWM, Jaegers SMHJ, et al: Usefulness of the SLICC/ACR damage index in patients with systemic lupus erythematosus. Arthritis Rheum 40(suppl9): S160, 1997.